Letter comments on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single-centre prospective study: Interaction between lymphopenia and anti-SARS-CoV-2 antibodies after two injections of the Pfizer-BioNTech vaccine in patients with cancers treated by chemotherapy or immunotherapy
关于以下研究的评论信:BNT162b2疫苗在接受抗癌治疗的实体瘤患者中的疗效和安全性——一项单中心前瞻性研究:接受化疗或免疫疗法治疗的癌症患者接种两剂辉瑞-BioNTech疫苗后淋巴细胞减少症与抗SARS-CoV-2抗体之间的相互作用
期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2021.09.048
Sekkate, Sakina; Stoeklé, Henri-Corto; Mabro, May; Billard, David; Kennel, Titouan; Vasse, Marc; Hervé, Christian; Beuzeboc, Philippe
SARS-CoV-2
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌